APA

Gombash S. E., Manfredsson F. P., Mandel R. J., Collier T. J., Fischer D. L., Kemp C. J., Kuhn N. M., Wohlgenant S. L., Fleming S. M. & Sortwell C. E. (20150219). Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. : Gene therapy.

Chicago

Gombash S E, Manfredsson F P, Mandel R J, Collier T J, Fischer D L, Kemp C J, Kuhn N M, Wohlgenant S L, Fleming S M and Sortwell C E. 20150219. Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. : Gene therapy.

Harvard

Gombash S. E., Manfredsson F. P., Mandel R. J., Collier T. J., Fischer D. L., Kemp C. J., Kuhn N. M., Wohlgenant S. L., Fleming S. M. and Sortwell C. E. (20150219). Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. : Gene therapy.

MLA

Gombash S E, Manfredsson F P, Mandel R J, Collier T J, Fischer D L, Kemp C J, Kuhn N M, Wohlgenant S L, Fleming S M and Sortwell C E. Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. : Gene therapy. 20150219.